Fetal porcine islet-like cell clusters transplanted to cynomolgus monkeys: An immunohistochemical study

Transplantation

Volumn 67, Issue 6, 1999, Pages 784-791

  Söderlund, Johan ^a   Wennberg, Lars ^b   Castaños Velez, Esmeralda ^a   Biberfeld, Peter ^a   Zhu, S ^b   Tibell, Annika ^b   Groth, Carl Gustav ^b   Korsoren, Olle ^c,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d Department of Medical Cell Biology ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GRAFT REJECTION; GRAFT SURVIVAL; MONKEY; NONHUMAN; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SWINE; XENOGRAFT;

EID: 0345628576     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199903270-00002     Document Type: Article

References (37)

1. + T cells. J Exp Med 1989; 170: 991.
2. + T cell-depleted mice. Transplantation 1990; 49: 849.
3. + macrophage and not a T lymphocyte. Transplantation 1995; 60: 594.
4. Wennberg L, Sundberg B, Rafael E, et al. Rejection of mixed allogeneic and xenogeneic islet grafts in rats immunosuppressed with cyclosporine A. Xenotransplantation 1997; 4: 228.
5. Auchincloss H. Xenogeneic transplantation. Transplantation 1988; 46: 1.
6. Wennberg L, Wallgren A, Sundberg B, et al. Efficacy of immunosuppressive drugs in islet xenotransplantation: a study in the pig-to-rat model. Xenotransplantation 1995; 2: 222.
7. Wennberg L, Sundberg B, Rafael E, et al. Efficacy of immunosuppressive drugs in islet xenotransplantation: leflunomide in combination with cyclosporine A and mycophenolate mofetil prevents islet xenograft rejection in the pig-to-rat model. Transplantation 1997; 63: 1234.
8. Korsgren O, Andersson A, Sandler S. Pretreatment of fetal porcine pancreas in culture with nicotinamide accelerates reversal of diabetes after transplantation to nude mice. Surgery 1993; 113: 205.
9. Korsgren O, Jansson L, Sandler S, Andersson A. Hyperglycemia-induced B-cell toxicity: the fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background. J Clin Invest 1990; 75: 2047.
10. Li S, Kaaya E, Feichtinger H, Biberfeld G, Biberfeld P. Immunohistochemical distribution of leucocyte antigens in lymphoid tissues of cynomolgus monkeys (Macaca fascicularis). J Med Primatol 1993; 22: 285.
11. Satake M, Kawagishi N, Rydberg L, et al. Limited specificity of xenoantibodies in diabetic patients transplanted with fetal porcine islet cell clusters: main antibody reactivity against α-linked galactose-containing epitopes. Xenotransplantation 1994; 1: 89.
12. Hamelmann W, Gray D, Cairns T, et al. Immediate destruction of xenogeneic islets in a primate model. Transplantation 1994; 58: 1109.
13. Korsgren O, Sandler S, Schnell-Landström AS, Jansson L, Andersson A. Large-scale production of fetal porcine pancreatic islet-like cell clusters: an experimental tool for studies of islet cell differentiation and xenotransplantation. Transplantation 1988; 45: 509.
14. Mellgren A, Schnell-Landström A, Petersson B, Andersson A. The renal subcapsular site offers better growth conditions for transplanted mouse pancreatic islets than the liver or spleen. Diabetologia 1986; 29: 670.
15. Killer WFA, Klempnauer J, Lück R, Steiniger B. Progressive deterioration of endocrine function after intraportal but not kidney subcapsular rat islet transplantation. Diabetes 1991; 40: 134.
16. Gray DW. Islet isolation and transplantation techniques in the primate. Surg Gynecol Obstet 1990; 170: 225.
17. Warnock GL, DeGroot T, Untch D, Ellis DK, Rajotte RV. The natural history of pure canine islet autografts in hepatic or splenic sites. Transplant Proc 1989; 21: 2617.
18. Kaufman DB, Morel P, Field MJ, Munn SR, Sutherland DER. Purified canine islet autografts: functional outcome as influenced by islet number and implantation site. Transplantation 1990; 50: 385.
19. Scharp DW, Marchetti P, Swanson C, et al. The effect of transplantation site and islet mass on long-term survival and metabolic and hormonal function of canine purified islet autografts. Cell Transplant 1992; 1: 245.
20. Kumagai-Braesch M, Satake M, Korsgren O, Andersson A, Möller E. Characterization of cellular human anti-porcine xenoreactivity. Clin Transplant 1993; 7: 273.
21. Kirk AD, Li RA, Kinch MS, et al. The human antiporcine cellular repertoire: in vitro studies of acquired and innate cellular responsiveness. Transplantation 1993; 55: 924.
22. Murray A, Khodadoust M, Pober J, Bothwell A. Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1994; 1: 57.
23. Yamada K, Seebach J, DerSimonian H, Sachs D. Human antipig T-cell mediated cytotoxicity. Xenotransplantation 1996; 3: 179.
24. Seebach J, Yamada K, McMorrow I, Sachs D. Xenogeneic human anti-pig cytotoxicity mediated by activated natural killer cells. Xenotransplantation 1996; 3: 188.
25. Satake M, Kawagishi N, Möller E. Direct activation of human responder T cells by porcine stimulator cells leads to T cell proliferation and cytotoxic T cell development. Xenotransplantation 1996; 3: 198.
26. Korbutt G, Aspeslet L, Rajotte R, et al. Natural human antibody-mediated destruction of porcine neonatal islet cell grafts. Xenotransplantation 1996; 3: 207.
27. Oriol R, Ye Y, Koren E, Cooper D. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56: 1433.
28. Maryanski JL, Pala P, Corradin G, Jordan BR, Cerottini J. H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide. Nature 1986; 324: 578.
29. Vanhove B, Bach F. Human xenoreactive natural antibodies: avidity and targets on porcine endothelial cells. Transplantation 1993; 56: 1251.
30. Turman M, Casali P, Notkins A, Bach F, Platt J. Polyreactivity and antigen specificity of human xenoreactive monoclonal and serum natural antibodies. Transplantation 1991; 52: 710.
31. Platt JL, Fischel RJ, Matas AJ, et al. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 1991; 52: 214.
32. Benda B, Karlsson-Parra A, Ridderstad A, Korsgren O. Xenograft rejection of porcine islet-like cell clusters in Ig or FcRg deficient mice. Transplantation 1996; 62: 1207.
33. Yuh D, Morris R. The immunopharmacology and immunosuppression by 15-deoxyspergualin. Transplantation 1993; 55: 578.
34. Dickneite G, Schorlemmer HV, Sedlaceck HH. Decrease of mononuclear phagocyte cell functions and prolongation of graft survival in experimental transplantation by (+/-)-15-deoxyspergualin. Int J Immunopharmacol 1987; 9: 559.
35. Sandberg JO, Korsgren O, Groth CG, Andersson A. 15-Deoxyspergualin prolongs pancreatic islet allo- and xenograft survival in mice. J Pharmacol Toxicol 1993; 73: 24.
36. Kumagai-Braesch M, Johansson Borg A, Satake M, Moller E. Characteristics of direct and indirect activation of human T cells against allogeneic and porcine xenogeneic cells/peptides. Xenotransplantation 1997; 4: 85.
37. Johansson-Borg A, Ohlman S. 15-Deoxyspergualine treatment of graft rejection in man: effect on mononuclear cells. Transpl Int 1992; 5: 219.